As one form of stroke, intracerebral hemorrhage (ICH) is a fatal cerebrovascular disease, which has high morbidity and mortality, and lacks of effective medical treatment. An increased in ltration of in ammatory cytokines coupled with pyroptotic cell death is involved in the pathophysiological process of ICH. However, little is known about whether concomitant fracture patients have the same progression of in ammation and pyroptosis. Hence, we respectively established mouse ICH model and ICH with bilateral tibial fracture model (MI) to explore the potential cross-talk between the above two injuries. We found that MI obviously reversed the expressions of pyroptosis-associated proteins, which were remarkably up-regulated at the acute phase after ICH. Similar results were observed in neuronal expressions via double immunostaining. Furthermore, brain edema was also signi cantly alleviated in mice who suffered MI, when compared with ICH alone. To better clarify the potent mechanisms mediated this cross-talk, recombinant mouse interleukin-13 (IL-13) was used to investigate its effect on pyroptosis in the mouse MI model, in which lower level of IL-13 was observed. Remarkably, IL-13 administration reawakened cell death, which was mirrored by the re-upregulation of pyroptosis-associated proteins and PI positive cell counts. The results of hemorrhage volume and behavioral tests further con rmed its critical role in regulating the neurological functions. Besides, IL-13-treated MI group showed poor outcomes of fracture healing. To sum up, our research indicates that controlling the IL-13 content in acute phase would be a promising target in in uencing the outcomes of brain injury and fracture, and meanwhile, provides new evidence in repairing compound injuries in clinics.